Dyne Therapeutics DYN
NASDAQ DYN
$16.11 -0.10 (-0.62%)
At close: Sep 30, 2026 · 4:00 PM EDT

Dyne Therapeutics (DYN) Times Interest Earned (2025)

Updated

Dyne Therapeutics' Times Interest Earned was -39.22 in Q3 2025.

Analysis

Dyne Therapeutics (DYN) Times Interest Earned (2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Times Interest Earned (Qtr)
1 Johnson & Johnson 645.01 Bn 563.54 Bn 17.26 Bn 25.41
2 AbbVie 465.23 Bn 438.39 Bn 12.70 Bn -
3 Merck 368.40 Bn 322.83 Bn 12.21 Bn -
4 Novartis Ag 278.02 Bn 233.89 Bn 11.24 Bn 10.28
5 Astrazeneca 254.57 Bn 228.13 Bn 12.86 Bn 7.27
6 Amgen 229.02 Bn 184.42 Bn 7.24 Bn 5.22
7 Gilead Sciences 187.74 Bn 161.85 Bn 6.22 Bn -42.08
8 Pfizer 163.75 Bn 110.70 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 133.45 Bn 105.45 Bn 2.84 Bn -
10 Dyne Therapeutics 2.69 Bn 2.69 Bn - -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 -39.22
Jun 30, 2025 -1,231.82
API Access

Dyne Therapeutics Times Interest Earned API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=times-interest-earned&ticker=DYN&period=max&api_key=YOUR_API_KEY